| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.3 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.3 |